QQ客服 官方微博 反馈留言

	Efavirenz in combination with n-acetyl cysteine shows improved outcome in treatment of hepatitis B.
	Liu, Lili; Chen, Longyan; Li, Fuhai; Zhang, Yan; Yang, Jie
刊名	BIOMEDICAL RESEARCH-INDIA
	2017
卷号	28期号:8页码:3362-3368
关键词	HIV Hepatitis B Antioxidant
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4586734
专题	山东大学
作者单位	Shandong Univ, Qilu Hosp, Childrens Med Ctr, Jinan 250012, Shandong, Peoples R China.
推荐引用方式 GB/T 7714	Liu, Lili,Chen, Longyan,Li, Fuhai,et al. Efavirenz in combination with n-acetyl cysteine shows improved outcome in treatment of hepatitis B.[J]. BIOMEDICAL RESEARCH-INDIA,2017,28(8):3362-3368.
APA	Liu, Lili,Chen, Longyan,Li, Fuhai,Zhang, Yan,&Yang, Jie.(2017).Efavirenz in combination with n-acetyl cysteine shows improved outcome in treatment of hepatitis B..BIOMEDICAL RESEARCH-INDIA,28(8),3362-3368.
MLA	Liu, Lili,et al."Efavirenz in combination with n-acetyl cysteine shows improved outcome in treatment of hepatitis B.".BIOMEDICAL RESEARCH-INDIA 28.8(2017):3362-3368.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。